US4961640A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method and apparatus of treatment of symptoms of the Irlen syndrom
Assignee: Individual
•
Filing: 1985-07-19
•
Granted: 1990-10-09
•
Expires: 2005-07-19
Abstract
Abstract Specially tinted lenses will provide substantial benefits to patients with various forms of visual disturbance caused by a recently identified functional disorder called the Irlen Syndrome of scotopic sensitivity, who show over-stimulation of receptor cells in the wavelength band of 425 to 575 nm. Symptomatically, the Irlen Syndrome is characterized by reduced visual resolution, impaired depth perception, impaired peripheral vision, and ocular vertigo. With use of the lenses the patients report improved visual resolution, increased comfort from reduced symptoms of eye strain, increased depth perception and peripheral vision, and reduced symptoms of ocular vertigo. The treatment includes experientially fitting the patient with lenses of an optimal color and transmission density, namely a predetermined attenuation in the 425-575 nm band. It has been determined according to the invention that pink and peach singly or in combination with blue, green, gray, purple, goldenrod, and yellow tints, can be effectively combined to achieve symptomatic relief. The color and density which is optimal for each patient must be determined individually for each patient and optimized as evaluated by pre-testing and post-testing on the Irlen Differential Perception Scale. Tinting and optical density are further optimized in each patient for near vision, far vision, and night vision.
Inventors
- 👤 Helen L. Irlen
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 03:21
CPC Classifications
G; G02; G02C; G02C5/00; G02C5/001; A; A61; A61B; A61B3/00; A61B3/02; A61B3/06; A61B3/066; G02C7/00; G02C7/10; G02C7/104
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
186 words
A method for the treatment of perceptual impairments caused by scotopic sensitivity, comprising the steps of: identifying and characterizing symptomatic indicia of said perceptual impairments; sequentially interposing one or more optical filters between the eye of a patient having said perceptual impairments and an object perceived with said impairments, each said optical filter having a percentage attenuation of at least 60% at selected wavelengths within the range above 425 and below 575 nanometers and having a substantially higher transmittance at wavelengths above 575 nanometers and below 425 nanometers, with the transmittance at 575 nanometers being greater by at least a factor of 2 than the minimum transmittance in the range between 425 and 575 nanometers, said filters being graduated with respect to each other in their spectral characteristics; comparing the symptomatic indicia of said perceptual impairments when viewing through each optical filter with said symptomatic indicia when not viewing through the optical filter to determine if said symptomatic indicia have been ameliorated; and identifying the filter or combination of filters that minimizes said symptomatic indicia to generate a prescription for the optimum filter for the patient.
Claim 2
Independent Claim
186 words
A method for the treatment of perceptual impairments caused by scotopic sensitivity, comprising the steps of: identifying and characterizing symptomatic indicia of said perceptual impairments; sequentially interposing one or more optical filters between the eye of a patient having said perceptual impairments and an object perceived with said impairments, each said optical filter having a percentage attenuation of at least 60% at selected wavelengths within the range above 425 and below 575 nanometers and having a substantially higher transmittance at wavelengths above 575 nanometers and below 425 nanometers, with the transmittance at 575 nanometers being greater by at least a factor of 2 than the minimum transmittance in the range between 425 and 575 nanometers, said filters being graduated with respect to each other in their spectral characteristics; comparing the symptomatic indicia of said perceptual impairments when viewing through each optical filter with said symptomatic indicia when not viewing through the optical filter to determine if said symptomatic indicia have been ameliorated; and identifying the filter or combination of filters that minimizes said symptomatic indicia to generate a prescription for the optimum filter for the patient.
Claim 3
Dependent Claim
32 words
The method of claim 1 wherein said step of interposing said optical filters between said eye of said patient and said object perceived with said perceptual impairments includes interposing graduated optical filters.
Claim 4
Dependent Claim
27 words
The method of claim 1 where said steps of interposing said optical filters includes interposing optical filters having graduated optical densities and substantially the same transmission spectrum.
Claim 5
Dependent Claim
26 words
The method of claim 1, where said step of interposing said optical filters includes interposing optical filters having graduated spectral characteristics with substantially constant optical densities.
Claim 6
Dependent Claim
31 words
The method of claim 1 where said steps of interposing and continually interposing said optical filters includes interposing optical filters having a tint selected from the group of pink and peach.
Claim 7
Dependent Claim
24 words
The method of claim 1 where said steps of interposing and continually interposing said optical filters includes interposing optical filters having a gray tint.
Claim 8
Dependent Claim
24 words
The method of claim 1 where said steps of interposing and continually interposing said optical filters includes interposing optical filters having a yellow tint.
Claim 9
Dependent Claim
24 words
The method of claim 1 where said steps of interposing and continually interposing said optical filters includes interposing optical filters having a purple tint.
Claim 10
Dependent Claim
24 words
The method of claim 1 where said steps of interposing and continually interposing said optical filters includes interposing optical filters having a goldenrod tint.
Claim 11
Dependent Claim
24 words
The method of claim 1 where said steps of interposing and continually interposing said optical filters includes interposing optical filters having a green tint.
Claim 12
Dependent Claim
30 words
The method of claim 1 where said step of interposing said optical filters includes interposing filters selected from the group of pink, blue, gray, peach, purple goldenrod and yellow tints.
Claim 13
Dependent Claim
49 words
The method of claim 1 where said step of interposing said optical filters includes interposing optical filters having a tint selected from the group of pink and peach, and in addition thereto, a superimposing optical filter selected from a group having blue, green, gray, purple goldenrod and yellow tints.
Claim 14
Dependent Claim
24 words
The method of claim 1 where said step of interposing said optical filters includes superimposing a plurality of optical filters having different transmission spectrums.
Claim 15
Dependent Claim
36 words
The method of claim 13 where said step of superimposing optical filters of differing color spectrums includes superimposing a plurality of optical filters selected from a group having pink, gray, peach, purple, goldenrod and yellow tints.
Claim 16
Independent Claim
164 words
A method for reducing visual impairment caused by the sensitivity of a patient to one or more bands of wavelengths within the range of 425 to 575 nanometers comprising: providing a plurality of filters each having an attenuation of at least 60% at a selected band of wavelengths within the range of 425-575 nanometers and a substantially higher transmittance above and below said selected band, with the transmittance at 575 nanometers being greater by at least a factor of 2 than the transmittance at the selected band of wavelengths, the selected band of wavelengths being different for various ones of said plurality of filters; sequentially interposing selected ones of said filters between an eye of the patient and an object being viewed by the patient; determining which filter or combination of filters most reduces the visual impairment of the patient when the object is viewed therethrough; and identifying the spectral characteristics of the filter or combination of filters that most reduces the visual impairment.
Claim 17
Independent Claim
164 words
A method for reducing visual impairment caused by the sensitivity of a patient to one or more bands of wavelengths within the range of 425 to 575 nanometers comprising: providing a plurality of filters each having an attenuation of at least 60% at a selected band of wavelengths within the range of 425-575 nanometers and a substantially higher transmittance above and below said selected band, with the transmittance at 575 nanometers being greater by at least a factor of 2 than the transmittance at the selected band of wavelengths, the selected band of wavelengths being different for various ones of said plurality of filters; sequentially interposing selected ones of said filters between an eye of the patient and an object being viewed by the patient; determining which filter or combination of filters most reduces the visual impairment of the patient when the object is viewed therethrough; and identifying the spectral characteristics of the filter or combination of filters that most reduces the visual impairment.
Claim 18
Dependent Claim
31 words
The method recited in claim 15 wherein the step of providing the plurality of filters includes providing a plurality of filters of different density for various ones of said selected bands.
Claim 19
Dependent Claim
23 words
The method recited in claim 1 further including the step of fabricating a single filter having the spectral characteristics defined by the prescription.
Claim 20
Dependent Claim
32 words
The method recited in claim 15 further including the step of fabricating a single filter having the spectral characteristics of the filter or combination of filters that most reduces the visual impairment.
References Cited (Backward Citations)
US2057983A
Cited
US3436353A
Cited
US3445153A
Cited
DE2307602A1
Cited
US4247177A
Cited
US4381136A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-10-08 | 1994-04-09 | 1994-10-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-10-08 | 1998-04-09 | 1998-10-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-10-08 | 2002-04-09 | 2002-10-09 | $7700.00 | Window Closed / Lapsed |